Warfarin Sodium tablets
Company: Barr LaboratoriesApproval Status: Approved March 1997
Treatment for: Anticoagulant, or "blood thinner" to keep blood clots from forming or getting larger
Areas: Cardiovascular / Cardiology
General Information
Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck?s anti-coagulant Coumadin, have been approved for marketing.
Warfarin Sodium tablets Drug Information
The Warfarin Sodium Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
